According to Wave Life Sciences's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 6.62847. At the end of 2023 the company had a P/S ratio of 5.31.
Year | P/S ratio | Change |
---|---|---|
2023 | 5.31 | -96.82% |
2022 | 167 | 3534.67% |
2021 | 4.59 | -76.01% |
2020 | 19.1 | 11.03% |
2019 | 17.2 | -79.97% |
2018 | 86.0 | -60.6% |
2017 | 218 | -47.22% |
2016 | 413 | -81.72% |
2015 | > 1000 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | N/A | N/A | ๐บ๐ธ USA |